期刊文献+

抗口蹄疫病毒phage-scFv及可溶性scFv的构建

Construction of Phage-scFv and Soluble scFv against Foot and Mouth Disease Virus
下载PDF
导出
摘要 利用重组DNA技术在抗口蹄疫病毒单克隆抗体1C 7 VH基因和VL基因之间导入一段连接肽[(G ly4Ser)3],采用重叠延伸拼接法,经聚合酶链反应(PCR)扩增获得scF v基因。将scF v基因克隆至噬菌粒pCANTAB 5E载体,转化E.coli TG 1,构建噬菌体抗体文库。用M 13KO 7辅助噬菌体挽救及固相口蹄疫病毒(FMDV)抗原对噬菌体抗体文库的三轮“吸附-洗脱-扩增”的淘洗,筛选出scFv阳性克隆。将阳性克隆转化E.coli BH 2151,通过异丙基硫代-β-D-半乳糖苷(IPTG)诱导可溶性scFv蛋白的表达。酶联免疫吸附实验(EL ISA)检测表明:scFv克隆表达的phage-scFv及可溶性scFv与FMDV亲和力高,特异性强。 The anti-foot-and-mouth disease virus (FMDV) single-chain Fv (scFv) gene was constructed by DNA recombinant technology. The 1C7VH and VL genes were assembled into scFv gene with a linker sequence (Gly4Ser)3 by splicing overlop extension and scFv gene was amplified by PCR. The scFv gene was subcloned into phagemid vector pCANTAB 5E. The phage scFv displaying library was constructed by male Escherichia coli TG1 transfected with resultant phagemid pCANTAB 5E-scFv. The scFv positive clone was obtained after the phage scFv displaying library was rescued by M13KO7 and biopanned with FMDV antigen for 3 rounds. Escherichia coli BH2151 was transfected with the positive clone and scFv protein was expressed by Escherichia coli BH2151 through the inducement of IPTG. The results of ELISA show that phage-scFv and soluble scFv, which were expressed by the selected scFv gene, have high affinity and specificity to FMDV.
出处 《华东理工大学学报(自然科学版)》 EI CAS CSCD 北大核心 2006年第8期933-938,共6页 Journal of East China University of Science and Technology
基金 上海交通大学基础研究项目
关键词 口蹄疫病毒 噬菌体-scFv 可溶性scFv 噬菌体展示技术 foot-and-mouth disease virus phage-scFv soluble scFv phage displaying technology
  • 相关文献

参考文献13

  • 1Doming E,Mateu M G,Martinez M A,et al.Genetic variability and antigenic diversity of foot-and-mouth disease virus[J].Appl Virol Res,1990,2:233-266.
  • 2Kitching R P.A recent history of foot-and-mouth disease virus[J].J Comparative Pathol,1998,118:89-108.
  • 3Samuel A R,Knowles N J.Foot-and-mouth disease virus:Cause of the recent crisis for the UK livestock industry[J].Trends in Genetics,2001,17:421-424.
  • 4Naessens J,Scheerlinck J P,Buysscher E V D,et al.Effective in vivo depletion of T cell subpopulations and loss of memory cells in cattle using mouse monoclonal antibodies[J].Vet Immunol Immunapathol,1998,64:219-234.
  • 5Barnett P V,Samuel A P,Pullen L,et al.Monoclonal antibodies,against O1 serotype food-and-mouth disease virus,from a natural bovine host,recognize similar antigenic features to those defined by the mouse[J].J Gen Virol,1998,79:1687-1697.
  • 6Orlandi R,Gussow D H,Jones P T,et al.Cloning immunoglobulin variable domains for expression by the polymerase chain reaction[J].Proc Natl Acad Sci USA,1989,86:3833-3837.
  • 7Huston J S,Levinson D,Mudgett-Hunter M,et al.Protein engineering of antibody binding sites:Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli[J].Proc Natl Acad Sci USA,1988,85:5879.
  • 8McCafferty J,Griffiths A D,Winter G,et al.Phage antibodies:Filamentous phage displaying antibody variable domains[J].Nature,1990,348:552-554.
  • 9曹盛丰,王欣,孙涛,陆苹,魏然,王国丰.抗口蹄疫病毒单克隆抗体1C7重轻链可变区基因的克隆及序列分析[J].中国预防兽医学报,2002,24(5):341-345. 被引量:1
  • 10Russell H.Recombinant PCR.PCR Protocols:A Guide to Methods and Application[M].New York:Academic Press,1990.177-183.

二级参考文献21

  • 1[1]Doming E, Mateu M G, Martinez M A, et al. Genetic variabilliy and antigenic diversity of foot-and-mouth disease virus [J]. Appl. Virol. Res.,1990,2:233~266.
  • 2[2]Archarya R, Fry E, Stuart D, et al. The three-dirnensionl structure of foot-and-mouth disease virus at 2.9A resolution[J]. Nature, 1989.337:709~716.
  • 3[3]Kitching R P. A recent history of foot-and-mouth disease virus[J]. Comparative Pathol., 1998,118:89~108.
  • 4[4]Marquardt O, Freiberg B, Antigenic variation among foot-and-mouth disease virus type A field isolates of 1997-1999 from Iram[J]. Veterinary Microbiology, 2000,74: 377~386.
  • 5[5]Tsai C P,Pan C H,Liu M y, et al. Molecular epidemiological studies on foot-and-mouth disease type O Taiwan viruses from the 1997 epidemic[J]. Veteinary Microbiology,2000,74:207~216.
  • 6[6]Zheng Z X. Biosynthetic peptide vaccine against foot-and-mouth disease virus. In Talwar G P, et al. eds. Recombinant and Synthetic Vaccines[M]. 1994,30~35. Narosa Publishing House, New Delhi, India.
  • 7[7]Naessens J,Scheerlinck J P, Buysscher E V D, et al. Effective in vivo depletion of T cell subpopulations and loss of memory cells in cattle using mouse monoclonal antibodies[J]. Vet. Immunol. Immunapathol., 1998,64:219~234.
  • 8[8]Barnett P V,Samuel A P,Pullen L, et al. Monoclonal antibodies,against Ol serotype food-and-mouth disease virus,from a natural bovine host, recognize similar antigenic features to those defined by the mouse[J]. Gen.Virol., 1998,79:1687~1697.
  • 9[9]Skerra A,Pluckthun A Assembly of a functional immunoglobulin Fv fragment in Escherichia coli[J]. Science, 1989,240:1038~1041.
  • 10[10]Li J, Wang Y,Wang Z, et al. Influences of amino acid sequences in FR1 region on binding activity of the scFv and Fab of an antibody of human gastric cancer cells[J]. Immunol. Letters,2000,71:157~165.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部